DrugPatentWatch Database Preview
Pliva Lachema Company Profile
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the competitive landscape for PLIVA LACHEMA, and what generic and branded alternatives to PLIVA LACHEMA drugs are available?
PLIVA LACHEMA has three approved drugs.
There is one tentative approval on PLIVA LACHEMA drugs.
Summary for Pliva Lachema
| US Patents: | 0 |
| Tradenames: | 3 |
| Ingredients: | 3 |
| NDAs: | 3 |
Drugs and US Patents for Pliva Lachema
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pliva Lachema | PACLITAXEL | paclitaxel | INJECTABLE;INJECTION | 077413-001 | Mar 12, 2008 | DISCN | No | No | Start Trial | Start Trial | |||||
| Pliva Lachema | CARBOPLATIN | carboplatin | INJECTABLE;INTRAVENOUS | 078631-001 | Dec 2, 2008 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Pliva Lachema | IRINOTECAN HYDROCHLORIDE | irinotecan hydrochloride | INJECTABLE;INJECTION | 078122-001 | Oct 31, 2008 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Pliva Lachema | CARBOPLATIN | carboplatin | INJECTABLE;INTRAVENOUS | 078631-004 | Dec 2, 2008 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Pliva Lachema | IRINOTECAN HYDROCHLORIDE | irinotecan hydrochloride | INJECTABLE;INJECTION | 078122-002 | Oct 31, 2008 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Pliva Lachema | CARBOPLATIN | carboplatin | INJECTABLE;INTRAVENOUS | 078631-003 | Dec 2, 2008 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Pliva Lachema | CARBOPLATIN | carboplatin | INJECTABLE;INTRAVENOUS | 078631-002 | Dec 2, 2008 | AP | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
